Month: August 2024

SmartCentres Declares Distribution for August 2024

Written by Customer Service on August 16, 2024. Posted in Dividend Reports And Estimates.

TORONTO, Aug. 16, 2024 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres”) (TSX: SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of August 2024 of $0.15417 per unit, representing $1.85 per unit on an annualized basis. The distribution will be payable on September 16, 2024 to unitholders of record as at August 30, 2024. About SmartCentres SmartCentres is one of Canada’s largest fully integrated REITs, with a best-in-class and growing mixed-use portfolio featuring 195 strategically located properties in communities across the country. SmartCentres has approximately $12.0 billion in assets and owns 35.2 million square feet of income producing value-oriented retail and first-class office properties with 98.2% in place and committed occupancy, on 3,500 acres...

UPDATE ON UNITS – BiomX Inc. Announces 1-for-10 Reverse Stock Split

Written by Customer Service on August 16, 2024. Posted in Public Companies.

In a release issued under the same headline yesterday by BiomX (NYSE American: PHGE), the third and fourth paragraphs have been updated to include information regarding adjustment of outstanding units following the reverse stock split GAITHERSBURG, Md., Aug. 16, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline yesterday by BiomX (NYSE American: PHGE), the third and fourth paragraphs have been updated to include information regarding adjustment of outstanding units following the reverse stock split. The updated release follows. BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it intends to effect a one-for-ten reverse split (the “Reverse Stock Split”)...

Apollo Funds, together with Rettig, complete the acquisition of a 94.53% stake in Purmo Group Plc

Written by Customer Service on August 16, 2024. Posted in Mergers And Acquisitions.

NEW YORK, Aug. 16, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds associated with its Clean Transition Equity strategy, together with strategic minority co-investor Rettig Oy Ab (“Rettig”), have through the special purpose vehicle Project Grand Bidco (UK) Limited completed the previously announced acquisition of a 94.53% equity ownership stake in Purmo Group Plc, a leader in sustainable indoor-climate solutions. Apollo funds and Rettig will look to acquire the remaining outstanding shares through Project Grand Bidco (UK) Limited and delist Purmo Group from the Nasdaq Helsinki Stock Exchange in the near future, resulting in Apollo funds owning 80% and Rettig 20% of Purmo Group. After delisting, as a privately owned business led by Chief Executive Officer John Peter Leesi and the current management...

Water Treatment Chemicals Market to Excel USD 43.05 Billion by 2031 | SkyQuest

Written by Customer Service on August 16, 2024. Posted in Mergers And Acquisitions.

Westford, USA, Aug. 16, 2024 (GLOBE NEWSWIRE) — Global Water Treatment Chemicals Market size was valued at USD 32.14 billion in 2022 and is poised to grow from USD 33.20 billion in 2023 to USD 43.05 billion by 2031, growing at a CAGR of 3.30% during the forecast period (2024-2031). Download a detailed overview: https://www.skyquestt.com/sample-request/water-treatment-chemicals-market SkyQuest projects that global water treatment chemicals market will attain a value of USD 43.05 Billion by 2031, with a CAGR of 3.30% over the forecast period (2024-2031). Water treatment chemicals are used in several ways, for example, in cleaning-up wastewater which has been contaminated or already used up at the industrial, commercial and domestic level. Within water treatment companies, such substances are almost always employed for purifying...

Global Machine Tools Market is Estimated to Develop at a Moderate 5.6% CAGR by 2031 | SkyQuest Technology

Written by Customer Service on August 16, 2024. Posted in Mergers And Acquisitions.

Westford, USA, Aug. 16, 2024 (GLOBE NEWSWIRE) — Global machine tools market size was valued at USD 84.00 billion in 2022 and is expected to grow from USD 88.70 billion in 2023 to reach USD 137.17 billion by 2031, at a CAGR of 5.6% during the forecast period (2024-2031). Download a detailed overview: https://www.skyquestt.com/sample-request/machine-tools-market SkyQuest projects that the machine tools market will attain a value of USD 137.17 billion by 2031, with a CAGR of 5.6% over the forecast period (2024-2031). Rapidly expanding industrial operations around the world are projected to bolster sales of machine tools over the coming years. Advancements in manufacturing technologies and the high adoption of automation in manufacturing will also shape the future machine tools demand outlook. Download a detailed overview: Browse...

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services

Written by Customer Service on August 16, 2024. Posted in Earnings Releases And Operating Results.

NAPLES, Fla., Aug. 16, 2024 (GLOBE NEWSWIRE) — via IBN — HealthLynked Corp. (OTCQB: HLYK), a leading provider of healthcare networking and technological innovation, has reported its financial results for the three- and six-month periods ending June 30, 2024. Reflecting the company’s ongoing efforts to streamline operations and transition its revenue streams from legacy clinical operations to app-based services, HealthLynked achieved significant cost reductions, leading to an 8% quarter-over-quarter improvement in its loss from operations. Financial Highlights:Revenue: The company reported revenue of $0.78 million in the second quarter of 2024, a 21% decrease from $1.00 million in the first quarter of 2024, and a 53% decline from $1.70 million in the second quarter of 2023. For the first half of 2024, revenue totaled...

Purple Biotech Reports Second Quarter 2024 Financial Results and Business Highlights

Written by Customer Service on August 16, 2024. Posted in Earnings Releases And Operating Results.

Positive randomized Phase 2 CM24 pancreatic cancer study interim data presented at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting demonstrates improvement in overall survival, progression free survival, objective response rate and all other efficacy endpoints in the combination of CM24+nivolumab and NAL-IRI/5FU/LV chemotherapy cohort Evaluating expansion of CM24 clinical program to a biomarker driven study in additional indications based on CEACAM1 novel oncology target on Neutrophil Extracellular Traps (NETs) in addition to enhancing immune response through the inhibition of CEACAM1 to CEACAM1 interactions Cash runway extended to Q3 2025 REHOVOT, Israel, Aug. 16, 2024 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class...

Kandi Technologies Reports Second Quarter 2024 Financial Results

Written by Customer Service on August 16, 2024. Posted in Earnings Releases And Operating Results.

Strong Financial Position with ~$220 million cash and cash equivalents Returned Capital to Shareholders via Active Share Repurchase Program Introduced Officially Licensed NFL Team Golf Carts Exclusively Available at Lowe’sJINHUA, China, Aug. 16, 2024 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company”, “we” or “Kandi”) (NASDAQ GS: KNDI), today announced its financial results for the second quarter of 2024. Second Quarter HighlightsTotal revenues increased to $39.1 million, up from $36.0 million in the same period of 2023. Off-road vehicles and associated parts were the primary driver of revenue, increasing by 11.3% y/y to $34.7 million, compared to $31.3 million in the same period of 2023. Net income was $1.6 million, or $0.02 income per fully diluted share, compared to net income of $4.4 million, or $0.06 income...

AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Written by Customer Service on August 16, 2024. Posted in Earnings Releases And Operating Results.

– Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications – Company to host conference call and webcast today, August 16th at 8:30 AM ET OCALA, Fla., Aug. 16, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported its financial results for the second quarter 2024. As previously announced, the Company will host a conference call and webcast today, Friday, August 16, 2024, at 8:30 AM ET (details below). “We continue to see great potential in Ampligen as we progress across our clinical development programs and look forward to results from our ongoing studies in the near future. Our entire team remains dedicated to patients and stockholders and will continue to drive momentum across our operational, clinical...

Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Written by Customer Service on August 16, 2024. Posted in Earnings Releases And Operating Results.

Following recent transactions and cost-cutting efforts, Sol-Gel’s cash runway is expected to extend into the first quarter of 2026 Ongoing Phase 3 clinical trial of SGT-610 for Gorlin Syndrome with over 30 clinical sites activated; Top-line results are expected by the second quarter of 2026 SGT-210 proof-of-concept study in patients suffering from Darier disease, a significant unmet medical need in dermatology, is ongoing Sol-Gel sells its rights in the Abbreviated New Drug Application (ANDA)drug product generic to Zoryve® Cream(roflumilast cream 0.3%) Following management realignment, Mr. Mori Arkin, the Company’s executive chairman and controlling shareholder to be appointed as Company’s interim CEO as of January 1, 2025, subject to shareholders approval Sol-Gel recently signed license agreements with respect to TWYNEO and EPSOLAY in...

Month: August 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals